AVITA Medical, Inc. is a therapeutic acute wound care company. The Company’s technologies optimize wound healing, effectively accelerating the time to patient recovery. At the forefront of its platform is the RECELL System for the treatment of thermal burn wounds and full-thickness skin defects. RECELL harnesses the healing properties of a patient’s own skin to create Spray-On Skin Cells, offering a solution for improved clinical outcomes at the point-of-care. In the United States, it also holds the exclusive rights to market, sell, and distribute Cohealyx, an AVITA Medical-branded collagen-based dermal matrix, and PermeaDerm, a biosynthetic wound matrix. Its technologies are designed to optimize skin restoration procedures, effectively accelerating patient healing and recovery. Its solutions improve the healing outcomes for patients with traumatic injuries and surgical repairs, addressing critical healing needs that arise from unpredictable and life-changing events.
公司代碼RCEL
公司名稱AVITA Medical Inc
上市日期Mar 18, 2012
CEOVance (Cary G)
員工數量260
證券類型Ordinary Share
年結日Mar 18
公司地址28159 Avenue Stanford
城市VALENCIA
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編91355
電話16613679170
網址https://www.avitamedical.com/
公司代碼RCEL
上市日期Mar 18, 2012
CEOVance (Cary G)